Moderna’s vaccine was authorized for emergency use in the U.S. in December 2020, about a week after the Pfizer vaccine. Before joining Moderna in 2011, Bancel spent five years as CEO of bioMérieux SA, a French diagnostics company. He worked with Eli Lilly for six years, serving as managing director, Belgium, and executive director of global manufacturing strategy and supply chain. Bancel holds a master of science degree in chemical engineering from the University of Minnesota, and an MBA from Harvard Business School.

Bancel speaks: “It is promising to see clinical and real-world evidence adding to the growing body of data on the effectiveness of the Moderna COVID-19 vaccine.”